| Title |
Methadone for chronic non‐cancer pain in adults
|
|---|---|
| Published in |
Cochrane database of systematic reviews, November 2012
|
| DOI | 10.1002/14651858.cd008025.pub2 |
| Pubmed ID | |
| Authors |
Simon Haroutounian, Ewan D McNicol, Arthur G Lipman<sup>a</sup> |
| Abstract |
Methadone belongs to a class of analgesics known as opioids, that are considered the cornerstone of therapy for moderate-to-severe pain due to life-threatening illnesses; however, their use in chronic non-cancer pain (CNCP) is controversial. Methadone has many characteristics that differentiate it from other opioids, which suggests that it may have a different efficacy and safety profile. |
X Demographics
The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 4 | 36% |
| Spain | 1 | 9% |
| United Kingdom | 1 | 9% |
| Unknown | 5 | 45% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 11 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 211 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 2 | <1% |
| Argentina | 1 | <1% |
| Spain | 1 | <1% |
| Unknown | 207 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 32 | 15% |
| Researcher | 25 | 12% |
| Other | 19 | 9% |
| Student > Ph. D. Student | 18 | 9% |
| Student > Doctoral Student | 15 | 7% |
| Other | 49 | 23% |
| Unknown | 53 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 88 | 42% |
| Nursing and Health Professions | 23 | 11% |
| Psychology | 10 | 5% |
| Agricultural and Biological Sciences | 8 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 8 | 4% |
| Other | 14 | 7% |
| Unknown | 60 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 April 2021.
All research outputs
#2,272,598
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#4,694
of 11,842 outputs
Outputs of similar age
#15,277
of 192,725 outputs
Outputs of similar age from Cochrane database of systematic reviews
#96
of 245 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,842 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 38.9. This one has gotten more attention than average, scoring higher than 61% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 192,725 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 245 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.